Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-045294
Filing Date
2024-11-05
Accepted
2024-11-05 16:15:08
Documents
17
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A alts-20241105.htm   iXBRL DEF 14A 547516
3 alts-20241105_g1.jpg GRAPHIC 114852
4 alts-20241105_g2.jpg GRAPHIC 132943
5 alts-20241105_g3.jpg GRAPHIC 132306
6 alts-20241105_g4.jpg GRAPHIC 105634
7 alts-20241105_g5.jpg GRAPHIC 161844
8 alts-20241105_g6.jpg GRAPHIC 139280
  Complete submission text file 0001628280-24-045294.txt   2928940

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alts-20241105.xsd EX-101.SCH 926
19 EXTRACTED XBRL INSTANCE DOCUMENT alts-20241105_htm.xml XML 33716
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19621 | Film No.: 241427645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)